1-3 of 3
Catherine Diefenbach
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study

Alex F. Herrera, Manish R. Patel, John M. Burke, Ranjana Advani, Bruce D. Cheson, Jeff P. Sharman, Elicia Penuel, Andrew G. Polson, Chen Di Liao, Chunze Li, Eva Schuth, Anjali Vaze, Divya Samineni, Rebecca Elstrom, James Cooper, Catherine Diefenbach
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1294–1301.
https://doi.org/10.1158/1078-0432.CCR-21-3261
Published: 01 April 2022
View article titled, Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study
Open the PDF for Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study in another window
Includes: Supplementary data
Journal Articles

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

Jatin J. Shah, Andrzej J. Jakubowiak, Owen A. O'Connor, Robert Z. Orlowski, R. Donald Harvey, Mitchell R. Smith, Daniel Lebovic, Catherine Diefenbach, Kevin Kelly, Zhaowei Hua, Allison J. Berger, George Mulligan, Hélène M. Faessel, Stephen Tirrell, Bruce J. Dezube, Sagar Lonial
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1): 34–43.
https://doi.org/10.1158/1078-0432.CCR-15-1237
Published: 03 January 2016
View article titled, Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma
Open the PDF for Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma in another window
Includes: Supplementary data
Journal Articles

New Strategies in Hodgkin Lymphoma: Better Risk Profiling and Novel Treatments

Catherine Diefenbach, Christian Steidl
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (11): 2797–2803.
https://doi.org/10.1158/1078-0432.CCR-12-3064
Published: 30 May 2013
View article titled, New Strategies in Hodgkin Lymphoma: Better Risk Profiling and Novel Treatments
Open the PDF for New Strategies in Hodgkin Lymphoma: Better Risk Profiling and Novel Treatments in another window